CRI Speaks

Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming CRI Speaks

Currently there are no upcoming events.

Past CRI Speaks

November 09, 20209:00 AM
CRI Speaks

7th International Symposium on Focused Ultrasound

CRI's Jill O'Donnell-Tormey, Ph.D., moderates the cancer immunotherapy panel on November 10, 2020, at 10:35 AM ET. ​

October 01, 20209:00 AM
CRI Speaks

Fifth Annual IO Combinations 360°

CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "Public-Private Partnerships Between Research Organizations and BioPharma to Accelerate Cancer Immunotherapies" panel on October 2, 2020, at 1 PM ET. 

September 22, 20203:00 PM
CRI Speaks

FierceBiotech Roundtable Webinar: ​ESMO Post-Show: Highlights from the virtual conference

CRI's Jill O'Donnell-Tormey, Ph.D., speaks on the "​ESMO Post-Show" webinar on September 22, 2020, at 3 PM ET.

June 24, 202011:00 AM
CRI Speaks

FUSF Webinar: Cancer Immunotherapy Treatment and Research in a COVID-19 World

The Focused Ultrasound Foundation (FUSF) hosts a special conversation with Jill O’Donnell-Tormey, Ph.D., CEO of the Cancer Research Institute (CRI), and Jessica Foley, Ph.D., chief scientific officer of FUSF.

May 27, 20203:00 PM
CRI Speaks

FiercePharma Virtual's ASCO Preview: What to Watch For

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "ASCO Preview" webinar on May 27, 2020, at 3 p.m. ET. 

May 26, 20209:00 AM
CRI Speaks

Sixth Annual Digital Immuno-Oncology Innovation Forum

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investor Panel" on May 27, 2020, at 12 p.m. CT. 

May 05, 20209:00 AM
CRI Speaks

31st Annual Cancer Progress Conference

CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investing into Oncology" and "Oncology Modalities Facing Off" panels.

February 26, 20209:00 AM
CRI Speaks

Sixth Annual Immuno-Oncology 360° Summit

CRI’s Vanessa Lucey, Ph.D., MBA, speaks on the "Landscape and Evolution of the Marketplace" panel on February 27, 2020.

December 04, 201911:30 AM
CRI Speaks

The Biotech’s Conundrum in Immuno-Oncology: Between a Rock and a Hard Place – Weighing Hot Versus Cold Tumors, CPI-Naïve Versus CPI-Experienced Patients

CRI's Vanessa Lucey, Ph.D., discusses the immuno-onocology landscape in this webinar for the biotechnology industry. 

December 02, 20191:00 PM
CRI Speaks

World Vaccine & Immunotherapy Congress West Coast 2019

On December 4, CRI's Vanessa Hubbard-Lucey, Ph.D., MBA, is giving a talk on "Challenges and opportunities in designing immuno-oncology trials: A non-profit perspective."

*Immunotherapy results may vary from patient to patient.